Overall rank by patents
#28,325
of 49,997 tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 15 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus).
The verdict
According to USPTO PatentsView, Calyxia ranks #28,325 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 15 technology areas.
USPTO PatentsView assignee plate
Corpus R28325 · Foreign Corporation #28,325 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Bury Sp.z.o.o. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Calyxia · this assignee
34 score
3D Lighting… · lowest
7 score
What this shows Calyxia's Innovation Score is 33.9/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Calyxia is a focused PatentsView assignee: 15 CPC subclasses with 100% of grants classified under B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2023. By volume, Calyxia sits between Bury Sp.z.o.o. and Cancer Hospital, Chinese Academy OF Medical Sciences.
Calyxia shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Bury Sp.z.o.o.
9 patents
C.M.C. S.p.A.
9 patents
C2Sense, Inc.
9 patents
C3 Corporation
9 patents
Cambridge Glycoscience Ltd
9 patents
Came S.p.A.
9 patents
Canadian Solar Manufacturing (CHANGSHU) Inc.
9 patents
Cancer Hospital, Chinese Academy OF Medical Sciences
9 patents
Calyxia
9 patents
What this shows Calyxia holds 9 patents at rank #28,320, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,320 in granted patent volume.
Other assignees with the most granted patents in Calyxia's primary technology class.
Calyxia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 46th percentile higher than 46% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 33.3% |
| 2021 | 2 | 22.2% |
| 2022 | 2 | 22.2% |
| 2023 | 1 | 11.1% |
| 2025partial year | 1 | 11.1% |
Top 15 of 15 technology areas
Overall rank by patents
#28,325
of 49,997 tracked assignees
33.9 out of 100
What to do with this data
Calyxia's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.